Table 1.
LGSIL (n:27) | ASCUS (n:40) | HGSIL (n:9) | p value | |
---|---|---|---|---|
HPV | 14 (51.9%) | 14 (35.0%) | 7 (77.7%) | 0.147 |
Type 6 | 3 (11.1 %) | 3 (7.5%) | 1 (11.1%) | 0.863 |
Type 11 | 0 (0%) | 2 (5.0%) | 0 (0%) | 0.397 |
Type 16 | 3 (11.1%) | 4 (10%) | 4 (44.4%) | 0.024* |
Type 18 | 1 (3.7%) | 5 (12.5%) | 1 (11.1%) | 0.464 |
Type 31 | 1 (3.7%) | 0 (0%) | 0 (0%) | 0.399 |
Type 51 | 1 (3.7%) | 0 (0%) | 0 (0%) | 0.399 |
Type 53 | 2 (7.4%) | 2 (5.0%) | 0 (0%) | 0.686 |
Type 58 | 1 (3.7%) | 1 (2.5%) | 0 (0%) | 0.832 |
Type 59 | 1 (3.7%) | 0 (0%) | 0 (0%) | 0.399 |
Type 61 | 0 (0%) | 2 (5.0%) | 1 (11.1%) | 0.295 |
Type 66 | 2 (7.4%) | 2 (5.0%) | 0 (0%) | 0.686 |
Type 70 | 0 (0%) | 1 (2.5%) | 0 (0%) | 0.634 |
Type 84 | 0 (0%) | 0 (0%) | 1 (11.1%) | 0.023* |
p<0.05, HPV: Human papilloma Virus, LGSIL: Low Grade Sguamous intraepithelial lesion, HGSIL: High Grade Squamous intraepithelial lesion, ASCUS: Atypical squamous cells of undetermined significance